Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 15/20 | 0.44 |
| ▸ | PPARG | P37231 | 5/20 | 0.39 |
| ▸ | PPARA | Q07869 | 4/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20636306 | 0.95 | ALOX5 (0.43) | ALOX5PPARGPPARANR1I2 | |
| SCHEMBL20634812 | 0.91 | ALOX5 (0.48) | ALOX5PPARGPPARANR1I2 | |
| SCHEMBL20636231 | 0.87 | ALOX5 (0.51) | ALOX5 | |
| SCHEMBL20634813 | 0.87 | ALOX5 (0.43) | ALOX5PPARGPPARANR1I2 | |
| SCHEMBL24970341 | 0.85 | ALOX5 (0.46) | ALOX5PPARGPPARANR1I2 | |
| SCHEMBL20635623 | 0.84 | ALOX5 (0.52) | ALOX5PPARGPPARANR1I2 | |
| SCHEMBL18349218 | 0.84 | ALOX5 (0.56) | ALOX5PPARGPPARAPPARDNR1I2 | |
| SCHEMBL20634811 | 0.82 | ALOX5 (0.63) | ALOX5PPARGPPARANR1I2 | |
| SCHEMBL20634802 | 0.81 | GSTO1 (0.54) | ALOX5NR1I2 | |
| SCHEMBL10307806 | 0.79 | ALOX5 (0.52) | ALOX5PPARGPPARANR1I2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230027148-A1 | MULTIFUNCTIONAL CONJUGATES | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2023-01-26 | — | — | US | disclosed |
| US-11400160-B2 | Multifunctional conjugates | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2022-08-02 | — | — | US | disclosed |
| US-20200164076-A1 | MULTIFUNCTIONAL CONJUGATES | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2020-05-28 | — | — | US | disclosed |
| WO-2019007447-A1 | MULTIFUNCTIONAL CONJUGATES | E.P.O.S IASIS RESEARCH AND DEVELOPMENT LIMITED (CY) | 2019-01-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230027148-A1 | MULTIFUNCTIONAL CONJUGATES | MKI67, ACP3, CD44 | ALOX5 1402/4885PPARG 621/4885PPARA 1122/4885 |
| US-20200164076-A1 | MULTIFUNCTIONAL CONJUGATES | MKI67, ACP3, CD44 | ALOX5 1462/4885PPARG 642/4885PPARA 1219/4885 |
| US-11400160-B2 | Multifunctional conjugates | MKI67, ACP3, CD44 | ALOX5 1462/4885PPARG 642/4885PPARA 1219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.